Immune responses mediating survival of naive BALB/c mice experimentally infected with lethal rodent malaria parasite, Plasmodium yoelii nigeriensis

Microbes and Infection

Volumn 2, Issue 5, 2000, Pages 473-480

  Singh, Balwan ^a   Nayak, Bishnu P ^a   Rao, Kanury V S ^a   Sharma, Pawan ^a  

^a Immunology Group   (India)

Author keywords

B cells; Plasmodium yoelii; Protective immunity; Rodent malaria parasite

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; LETHALITY; MALARIA; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; PRIMARY INFECTION; PRIORITY JOURNAL; SURVIVAL TIME; T LYMPHOCYTE; VACCINATION;

ANIMALIA; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; PLASMODIUM YOELII NIGERIENSIS; PROTOZOA; RODENTIA;

EID: 0034120646     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)00321-X     Document Type: Article

References (27)

1. Druilhe P., Bouharoun-Tayoun H. Natural immunities. Res. Immunol. 142:1991;637-643.
2. Druilhe P., Perignon J.L. Mechanisms of defense against P. falciparum asexual blood stages in humans. Immunol. Lett. 41:1994;115-120.
3. World Health Organization Malaria. WHO Fact Sheet (revised). 94:1996;1-3.
4. Brasseur P., Ballet J.J., Druilhe P. Impairment of Plasmodium falciparum specific antibody response in severe malaria. J. Clin. Microbiol. 228:1990;265-268.
5. Sedegah M., Finkelman F., Hoffman S.L. Interleukin-12 induction of interferon γ-dependent protection against malaria. Proc. Natl. Acad. Sci. USA. 91:1994;10700-10702.
6. Stevenson M.M., Tam M.F., Wolf S.F., Sher A. IL-12 induced protection against blood stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155:1995;2545-2556.
7. Yoshimoto T., Yoneto T., Waki S., Nariuchi H. Interleukin-12-dependent mechanisms in the clearance of blood-stage murine malaria parasite Plasmodium berghei XAT, an attenuated variant of P. berghei NK 65. J. Infect. Dis. 177:1998;1674-1681.
8. Yoshimoto T., Takahama Y., Wang C.R., Yoneto T., Waki S., Nariuchi H. A pathogenic role of IL-12 in blood-stage murine malaria lethal strain Plasmodium berghei NK 65 infection. J. Immunol. 160:1998;5500-5505.
9. Good M.F., Kaslow D.C., Miller L.H. Pathways and strategies for developing a malaria blood-stage vaccine. Ann. Rev. Immunol. 16:1998;57-87.
10. Miller L.H., Hoffman S.L. Research toward vaccines against malaria. Nat. M. 4:1998;520-524.
11. Qureshi S.T., Skamene E., Malo D. Comparative genomics and host resistance against infectious diseases. Emerging Infect. Dis. 5:1999;36-47.
12. Foote S.J., Burt R.A., Baldwin T.M., Presente A., Roberts A.W., Laural Y.L., Lew A.M., Marshall V.M. Mouse loci for malaria-induced mortality and the control of parasitemia. Nat. Genet. 17:1997;380-381.
13. Fortin A., Belouchi A., Tang M.F., Cardon L., Skamene E., Stevenson M.M., Gros P. Genetic control of blood parasitemia in mouse malaria maps to chromosome 8. Nat. Genet. 17:1997;382-383.
14. Sharma M.R., Sharma M.C., Tripathy L.M., Pandey V.C., Maitra S.C. Neuropathological studies on Plasmodium yoelii nigeriensis-induced malaria in mice. J. Comp. Pathol. 110:1994;313-317.
15. Waki S., Yonome I., Suzuki M. Plasmodium yoelii: induction of attenuated mutants by irradiation. Exp. Parasitol. 62:1986;316-321.
16. Wozencraft A.O., Croft S.L., Sayers G. Oxygen radical release by adherent cell populations during the initial stages of a lethal rodent malarial infection. Immunology. 56:1985;523-531.
17. National Institutes of Health. Guide for the Care and Use of Laboratory Animals, NIH publication no. 86-23. 1985;U. S. Department of Health and Human Services, Washington, DC.
18. Bharadwaj A., Sharma P., Joshi S.K., Singh B., Chauhan V.S. Induction of protective immune responses by immunization with linear multiepitope peptides based on conserved sequences from Plasmodium falciparum antigens. Infect. Immun. 66:1998;3232-3241.
19. Sharma P., Kumar A., Singh B., Bharadwaj A., Sailaja V.N., Adak T., Kushwaha A., Malhotra P., Chauhan V.S. Characterization of protective epitopes in a highly conserved Plasmodium falciparum antigenic protein containing repeats of acidic and basic residues. Infect. Immun. 66:1998;2895-2904.
20. Sharma P., Bharadwaj A., Bhasin V.K., Sailaja V.N., Chauhan V.S. Antibodies to a conserved-motif peptide sequence of the Plasmodium falciparum TRAP and CS protein recognize a 78-kDa protein in the asexual blood stages of the parasite and inhibit merozoite invasion in vitro. Infect. Immun. 64:1996;2172-2179.
21. Vijayakrishnan L., Sarkar S., Roy R.P., Rao K.V.S. B cell responses to a peptide epitope. IV. Subtle sequence changes in flanking residues modulate immunogenicity. J. Immunol. 159:1997;1809-1819.
22. Lambros C., Vanderberg J. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:1979;418-420.
23. Cohen S., Mc Gregor I.A., Carrington S.C. Gamma globulin and acquired immunity to malaria. Nature (London). 192:1961;733-737.
24. Bouharoun-Tayoun H., Attanath P., Sebchareon A., Chongsuphajaisiddhi T., Druilhe P. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. M. 172:1990;1633-1641.
25. + T cells from immune animals does not transfer immunity to blood stage Plasmodium yoelii malaria. J. Immunol. 144:1990;1069-1074.
26. Daly T.M., Long C.A. Humoral responses to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. J. Immunol. 155:1995;236-243.
27. + T cells. J. Immunol. 159:1997;3400-3411.